| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/01/1989 | CN1030748A Vinyl substituted radiohalogen conjugates for protein labeling |
| 01/31/1989 | US4801690 Novel lectins derived from bacterial pili |
| 01/31/1989 | US4801689 Isolation from mammalian oxiduct, absorption onto lecithin immobilized on support, then separation |
| 01/31/1989 | US4801687 Monoclonal antibody purification process using protein A |
| 01/31/1989 | US4801686 Suspension, microbial cells, breaking, extraction |
| 01/31/1989 | US4801685 Microbial production of mature human leukocyte interferon K and L |
| 01/31/1989 | US4801684 Process for obtaining insulin precursors from reaction mixtures resulting from the folding of insulin precursors from the corresponding S-sulfonates |
| 01/31/1989 | US4801609 Mercapto-acylamino acid antihypertensives |
| 01/31/1989 | US4801578 Muramylpeptide-glycoprotein immunostimulant derivatives, their preparation and their use in medication |
| 01/31/1989 | US4801577 Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists |
| 01/31/1989 | US4801576 Polypeptides |
| 01/31/1989 | US4801575 Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
| 01/31/1989 | US4801542 Expression of biologically active PDGF analogs in eucaryotic cells |
| 01/31/1989 | US4801537 Vector for expression of polypeptides in bacilli |
| 01/31/1989 | US4801536 Method for producing heterologous proteins |
| 01/31/1989 | US4801530 Detectors, trypanosoma, vectors, plasmids, bacteriophage, dna |
| 01/31/1989 | US4801456 Growth hormone-releasing factor analogs |
| 01/31/1989 | CA1249699A1 Retro-inverso analogue of the (5-14) decapeptide of equine angiotensinogen, as a specific renin inhibitor with high resistance to enzymatic hydrolysis |
| 01/26/1989 | WO1989000689A1 High resolution electrophoretic gel and method for separating serum proteins |
| 01/26/1989 | WO1989000604A1 Method for improving translation efficiency |
| 01/26/1989 | WO1989000603A1 A method for the expression of recombinant genes under stimulation from an inducively expressed activator protein |
| 01/26/1989 | WO1989000582A2 Human granulocyte-macrophage colony stimulating factor and muteins thereof |
| 01/26/1989 | WO1989000581A1 Lectines fixing beta-d-galactoside |
| 01/26/1989 | WO1989000580A1 Superactive human insulin analogues |
| 01/26/1989 | WO1989000579A1 Purification of gm-csf |
| 01/26/1989 | WO1989000446A1 Affinity separating using immobilized flocculating reagents |
| 01/26/1989 | WO1989000428A1 Use of atrial peptide antibodies, receptor antagonists, and atrial peptide synthesis inhibitors in controlling renal and systemic vasodilation in diabetes mellitus |
| 01/26/1989 | WO1989000166A3 Growth hormone related peptide |
| 01/26/1989 | WO1988007576A3 Vascular anticoagulant proteins, dnas which code for them, manufacture and application thereof |
| 01/25/1989 | EP0300988A2 Tissue factor inhibitor |
| 01/25/1989 | EP0300973A1 Physiologically active substances, a process for the preparation thereof and pharmaceutical compositions containing them |
| 01/25/1989 | EP0300849A1 Process for the chemical modification of protides, and products so modified |
| 01/25/1989 | EP0300741A2 Human thymopoietin |
| 01/25/1989 | EP0300737A2 Calcitonin gene related peptide derivatives |
| 01/25/1989 | EP0300487A2 Enzymatically inactive, immunologically active beta-galactosidase muteins |
| 01/25/1989 | EP0300466A1 Characterization and structure of genes for protease A and protease B from streptomyces griseus |
| 01/25/1989 | EP0300459A2 Human pancreatic secretory trypsin inhibitor |
| 01/25/1989 | EP0300431A2 Method of radiolabeling chelating compounds comprising sulfur atoms with metal radionuclides |
| 01/25/1989 | EP0300287A2 Process for the reduction of ketones |
| 01/25/1989 | EP0300213A1 Hepatitis a viral peptide particle immunogens |
| 01/25/1989 | EP0300102A1 Improved method of obtaining immune regulatory factors by mammal immunization |
| 01/25/1989 | EP0300071A1 Process for the separation and purification of organic substances from impurities |
| 01/25/1989 | EP0300031A1 Immunosuppressive peptides and methods of use |
| 01/25/1989 | EP0300030A1 Human proteins having anticoagulant and anti-inflammatory activity |
| 01/25/1989 | EP0299965A1 Antigenic analogues of platelet activating factor (paf) |
| 01/25/1989 | EP0299963A1 Renin inhibitors having a lactam pseudo dipeptide. |
| 01/25/1989 | CN1030645A Immunodiagnostic assays using chimeric antigens |
| 01/25/1989 | CN1030609A Protein with 8th activity factor,process for its preparation using genetic engineering cell and pharmaceutical composition containing it |
| 01/25/1989 | CN1030589A Urinary follicle stimulating hormone |
| 01/24/1989 | US4800191 Luteinizing hormone releasing hormone, peptides |
| 01/24/1989 | CA1249399A1 Process for preparing v.sub.1-vasopressin antagonists |
| 01/24/1989 | CA1249398A1 Process for preparing basic v.sub.1-vasopressin antagonists |
| 01/24/1989 | CA1249396A1 Partially retro-inverted decapeptide as a specific renin inhibitor with high resistance to enzymatic hydrolysis |
| 01/24/1989 | CA1249395A1 Human leukemia virus-related peptides, a process for production thereof, antibodies of the peptides and a process for production of the antibodies |
| 01/24/1989 | CA1249222A1 Antibody compositions of therapeutic agents having an extended serum half-life |
| 01/19/1989 | DE3822557A1 Somatostatins |
| 01/19/1989 | DE3722673A1 DNA coding for plasminogen activator inhibitor type 2 (PAI-2) |
| 01/19/1989 | DE3710430A1 Vascular anticoagulant proteins, DNA which encode these, process for their preparation and their use |
| 01/19/1989 | DE3710364A1 Vascular anticoagulant proteins, DNA which encode these, process for their preparation and their use |
| 01/18/1989 | EP0299828A1 Bactericidal and/or bacteriostatic peptides, process for their isolation, their production and their applications |
| 01/18/1989 | EP0299810A1 Process for the production of polypeptides by recombinant DNA |
| 01/18/1989 | EP0299782A2 Expression vectors for the production of human Granulocyte-Macrophage Colony Stimulation Factor in a mammalian cell host(18.05.92) |
| 01/18/1989 | EP0299746A1 Purification of GM-CSF |
| 01/18/1989 | EP0299707A2 Glycopeptide antibiotics |
| 01/18/1989 | EP0299706A2 Nonglycosylated plasminogen activator and method of preparation |
| 01/18/1989 | EP0299673A1 Rubella E1 glycoprotein antigens |
| 01/18/1989 | EP0299552A1 A process for transforming cells |
| 01/18/1989 | EP0299402A2 LHRH antagonists, their manufacture and pharmaceutical compositions thereof |
| 01/18/1989 | EP0299397A2 Peptides with vasorelaxing, natriuretic and diuretic activities, preparation process, agents containing them and their use |
| 01/18/1989 | EP0299354A2 Monoclonal antibodies against protein E7 of the human papilloma virus type 16, their production process and their use |
| 01/18/1989 | EP0299303A2 Eucaryotic expression vectors with multimeric enhancer subelements, process for their preparation and use |
| 01/18/1989 | EP0299242A2 Heterologous viral peptide particle immunogens |
| 01/18/1989 | EP0299206A2 Recombinant human ADF |
| 01/18/1989 | EP0299205A1 Sustained release microcapsules and method for the production thereof |
| 01/18/1989 | EP0299127A1 A method for the expression of recombinant genes under stimulation from an inducively expressed activator protein |
| 01/18/1989 | EP0299108A1 DNA-molecules coding for FMDH control regions and structured gene for a protein having FMDH-activity and their uses |
| 01/18/1989 | CN1030442A Plant tissue transformation |
| 01/18/1989 | CN1030425A Pasteurizable, freeze-driable hemoglobin-based blood substitute |
| 01/17/1989 | US4798886 Mutual separation of proteins |
| 01/17/1989 | US4798885 Compositions of hormonally active human and porcine inhibin containing an α chain and 62 chain |
| 01/17/1989 | US4798821 Cyclic hexa; octa- and oligopeptides |
| 01/17/1989 | US4798807 Monoclonal antibodies and method for detecting dioxins and dibenzofurans |
| 01/17/1989 | US4798800 Process for isolating human globular domain NC1 of basal membrane collagen from human tissue |
| 01/17/1989 | US4798797 Retrovirus associated with lymphadenopathies and adapted to continuous lines of lymphoblastoid B cells, capable of producing retrovirus continuously and process for their production |
| 01/17/1989 | US4798790 Monoclonal antibody specific for a pigmentation associated antigen |
| 01/17/1989 | US4798789 Plasmid vectors |
| 01/17/1989 | US4798787 Polyclonal |
| 01/17/1989 | CA1249100A1 Derivatives of peptides, their preparation, and compounds including them |
| 01/17/1989 | CA1249097A1 Polymers based on polyvinylene carbonate and/or polyhydroxymethylene, processes for their preparation and their use |
| 01/17/1989 | CA1248894A1 Synthetic peptide-based anti-rabies compositions and methods |
| 01/17/1989 | CA1248874A1 Process for the preparation of antitumoral glycoproteins modified on their carbohydrate units |
| 01/12/1989 | WO1989000293A1 A method for sample extraction, purification, concentration and quantification of low molecular weight organic compounds and an analytical kit for carrying out said method |
| 01/12/1989 | WO1989000200A1 Peptides and antibodies that inhibit platelet adhesion |
| 01/12/1989 | WO1989000199A1 Therapeutic antimicrobial polypeptides, their use and methods for preparation |
| 01/12/1989 | WO1989000198A1 Recombinant fibroblast growth factors |
| 01/12/1989 | WO1989000197A1 Improved processes for the treatment of vascular disease |
| 01/12/1989 | WO1989000196A1 Virus proteins having reduced o-linked glycosylation |
| 01/12/1989 | WO1989000195A1 Process for immobilization of biological material by cross-linking with polyazetidine |
| 01/12/1989 | WO1989000194A1 Inhibition of eucaryotic pathogens and neoplasms and stimulation of fibroblasts and lymphocytes with lytic peptides |
| 01/12/1989 | WO1989000192A1 Production of kallikrein |